Safety of degludec versus glargine in type 2 diabetes

Steven P. Marso, John B. Buse

Research output: Contribution to journalLetter

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1995-1996
Number of pages2
JournalNew England Journal of Medicine
Volume377
Issue number20
DOIs
StatePublished - Nov 16 2017

Fingerprint

Type 2 Diabetes Mellitus
Safety
Insulin Glargine
insulin degludec

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Safety of degludec versus glargine in type 2 diabetes. / Marso, Steven P.; Buse, John B.

In: New England Journal of Medicine, Vol. 377, No. 20, 16.11.2017, p. 1995-1996.

Research output: Contribution to journalLetter

@article{4e8bf7f062014231b1b555c028a45729,
title = "Safety of degludec versus glargine in type 2 diabetes",
author = "Marso, {Steven P.} and Buse, {John B.}",
year = "2017",
month = "11",
day = "16",
doi = "10.1056/NEJMc1712575",
language = "English (US)",
volume = "377",
pages = "1995--1996",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "20",

}

TY - JOUR

T1 - Safety of degludec versus glargine in type 2 diabetes

AU - Marso, Steven P.

AU - Buse, John B.

PY - 2017/11/16

Y1 - 2017/11/16

UR - http://www.scopus.com/inward/record.url?scp=85033772095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033772095&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1712575

DO - 10.1056/NEJMc1712575

M3 - Letter

C2 - 29141162

AN - SCOPUS:85033772095

VL - 377

SP - 1995

EP - 1996

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 20

ER -